Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0193 Transporter Info | ||||
| Gene Name | SLC25A31 | ||||
| Transporter Name | Adenine nucleotide translocator 4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Direct binding to SLC25A31 gene | [1] | ||||
|
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Myc proto-oncogene protein (MYC) can directly bind to the SLC25A31 gene, which in turn affects the expression or function of the drug transporter Adenine nucleotide translocator 4. | |||||
|
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Repression of SLC25A31 gene in health condition | [2] | ||||
|
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
|
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
|
Tissue |
Embryo | |||||
|
Related DT Changes |
Down regulating | |||||
|
Experimental Material |
Mouse embryo embryonic stem cells (ES-R1) | |||||
|
Detailed Description |
Transcription factor E2F6 (E2F6) has been reported to repress the transcription of SLC25A31 gene in health condition, which leads to a decreased expression of the drug transporter Adenine nucleotide translocator 4. | |||||
|
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC25A31 gene in health condition | [3] | ||||
|
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC25A31 gene in health condition, which leads to an affected expression of the drug transporter Adenine nucleotide translocator 4. | |||||
|
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Activation of SLC25A31 gene in prostate cancer condition | [4] | ||||
|
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Up regulating | |||||
|
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC25A31 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Adenine nucleotide translocator 4. | |||||
|
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
|
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC25A31 gene in epithelial ovarian cancer condition | [5] | ||||
|
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC25A31 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Adenine nucleotide translocator 4. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.